With Novo Nordisk's patent gone in India, a dozen generics have flooded in at a fraction of the price, and a market of 10 crore diabetics is waiting
01-Jun-2026•Value Research Team
Domestic mutual funds that own foreign equity
6 min read•By Aakar Rastogi
Welcome to the New Value Research!
2 min read•By Value Research
HUL is a great business. Is it a great stock?
4 min read•By Satyajit Sen